Bleomycin Export Market Intelligence: India's 206 Suppliers Shipping to 119 Countries — TransData Nexus 2026

Q: Who are the top bleomycin exporters from India?

The top bleomycin exporters from India are: 1. VENUS REMEDIES LIMITED — $1.2M (21.7% market share); 2. NAPROD LIFE SCIENCES PRIVATE LIMITED — $485.6K (8.7% market share); 3. INFUGEN PHARMA PRIVATE LIMITED — $404.6K (7.3% market share); 4. NV REMEDIES PRIVATE LIMITED — $290.8K (5.2% market share); 5. VIVALIA REMEDIES PRIVATE LIMITED — $277.5K (5.0% market share). Together they account for 47.9% of India's total bleomycin export value.

Q: What is the total export value of bleomycin from India?

The total export value of bleomycin from India is $5.6M USD, recorded across 1,101 shipment transactions from 206 active exporters to 119 destination countries. The average shipment value is $5.1K.

Q: Which countries import bleomycin from India?

India exports bleomycin to 119 countries worldwide. The top importing countries are: SOUTH AFRICA (9.9% share, $554.0K), MOZAMBIQUE (9.9% share, $548.9K), UZBEKISTAN (6.3% share, $351.9K), MEXICO (6.2% share, $346.6K), COLOMBIA (6.2% share, $345.7K). These five markets account for 38.6% of total export value.

Q: What is the HS code for bleomycin exports from India?

The primary HS code for bleomycin exports from India is 30049049. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of bleomycin exports from India?

The average unit price for bleomycin exports from India is $8.22 USD per unit, with prices ranging from $0.01 to $218.48 depending on formulation, packaging, and order volume. The total market is valued at $5.6M across 1,101 shipments.

Q: Which ports handle bleomycin exports from India?

The primary ports for bleomycin exports from India are SAHAR AIR (26.2% of shipments), SAHAR AIR CARGO ACC (INBOM4) (22.5% of shipments), DELHI AIR CARGO ACC (INDEL4) (15.5% of shipments), DELHI AIR (11.3% of shipments), Bombay Air (6.4% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of bleomycin?

India is one of the world's leading exporters of bleomycin due to its large base of 206 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports bleomycin to 119 countries, demonstrating 61% global market coverage.

Q: What certifications do Indian bleomycin exporters need?

Indian bleomycin exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import bleomycin from India?

There are 426 registered buyers importing bleomycin from India, spread across 119 countries. The repeat buyer rate is 43.9%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top bleomycin supplier from India?

VENUS REMEDIES LIMITED is the leading bleomycin exporter from India with a market share of 21.7% and total export value of $1.2M across 134 shipments. The top 5 suppliers together control 47.9% of total export value.

Suresh Sormare

Bleomycin

India Pharmaceutical Trade Intelligence

$5.6M206 Suppliers119 CountriesHS 30049049

ExportsIndia → SOUTH AFRICA9.9%India → MOZAMBIQUE9.9%

ImportsNETHERLANDS → India$1.4K CANADA → India$814

#1 Supplier: VENUS REMEDIES

Bleomycin Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Bleomycin to the World

Between 2022 and 2026, India exported $5.6M worth of bleomycin across 1,101 verified shipments to 119 countries — covering 61% of world markets in the Advanced Oncology segment. The largest destination is SOUTH AFRICA (9.9%). VENUS REMEDIES LIMITED leads with a 21.7% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Bleomycin export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Bleomycin export data snapshot — $5.6M · 206 exporters · 119 countriesTransData Nexus · Indian Customs Data

Top Bleomycin Exporters from India

206 active exporters · Ranked by export value

View all 206 →

Top Bleomycin Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	VENUS REMEDIES LIMITED	$1.2M	134	21	21.7%
2	NAPROD LIFE SCIENCES PRIVATE LIMITED

Top Countries Importing Bleomycin from India

119 destination markets · Ranked by import value

All 119 countries →

Top Countries Importing Bleomycin from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	SOUTH AFRICA	$554.0K	9.9%
2	MOZAMBIQUE	$548.9K	9.9%
3	UZBEKISTAN	$351.9K	6.3%
4	MEXICO	$346.6K	6.2%
5	COLOMBIA	$345.7K	6.2%
6	HUNGARY	$336.2K	6.0%
7	EGYPT	$310.8K	5.6%
8	UKRAINE	$237.0K	4.3%
9	SAUDI ARABIA	$189.1K	3.4%
10	UNITED STATES	$160.2K	2.9%

SOUTH AFRICA is India's largest bleomycin export destination, absorbing 9.9% of total exports worth $554.0K. The top 5 importing countries — SOUTH AFRICA, MOZAMBIQUE, UZBEKISTAN, MEXICO, COLOMBIA — together account for 38.6% of India's total bleomycin export value. The remaining 114 destination countries collectively receive the other 61.4%, indicating a well-diversified global distribution network spanning all major continents.

Who Supplies Bleomycin to India?

4 origin countries · Total import value: $2.9K

India imports bleomycin from 4 countries with a combined import value of $2.9K. The largest supplier is NETHERLANDS ($1.4K, 2 shipments), followed by CANADA and UNITED KINGDOM. All values are from Indian Customs (DGFT) import records.

Countries Supplying Bleomycin to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	NETHERLANDS	$1.4K	2	47.7%
2	CANADA	$814	1	28.2%
3	UNITED KINGDOM	$456	3	15.8%
4	UNITED STATES	$241	1	8.3%

NETHERLANDS is the largest supplier of bleomycin to India, accounting for 47.7% of total import value. Click any country to see detailed supplier and buyer data for that import corridor.

Regulatory Landscape — Bleomycin

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, Bleomycin has been approved by the FDA for various oncological indications. The original New Drug Application (NDA) for Bleomycin sulfate (Blenoxane) was approved on February 20, 1996, for the treatment of malignant pleural effusion, with exclusivity ending on February 20, 2003. Additionally, Bleomycin received orphan drug designation on September 17, 1993, for the treatment of malignant pleural effusion. The FDA's Orange Book lists multiple approved Abbreviated New Drug Applications (ANDAs) for Bleomycin sulfate, indicating the presence of generic competition. Notably, the ANDA for Bleomycin sulfate by Pharmacia was approved on June 3, 1996. The substantial number of active Indian exporters (206) underscores the competitive landscape and the importance of adhering to stringent FDA regulations to ensure market access.

2EU & UK Regulatory Framework

In the European Union, Bleomycin has been subject to regulatory scrutiny. A notable instance occurred in March 2009 when the European Medicines Agency (EMA) completed a referral procedure concerning Bleomycin powder for solution for injection (15 U/vial) from Pharmachemie BV. The Committee for Medicinal Products for Human Use (CHMP) concluded that the benefits outweighed the risks, leading to the granting of marketing authorization across EU Member States. (ema.europa.eu) This decision highlights the importance of harmonized regulatory assessments within the EU. Manufacturers exporting to the EU and UK must comply with Good Manufacturing Practice (GMP) requirements as stipulated by the EMA and the UK's Medicines and Healthcare products Regulatory Agency (MHRA). These standards ensure product quality and safety, necessitating rigorous adherence by Indian exporters to maintain market access.

3WHO Essential Medicines & Global Standards

Bleomycin is included in the World Health Organization's (WHO) Model List of Essential Medicines, underscoring its critical role in cancer treatment. This inclusion facilitates its adoption in national formularies worldwide. Compliance with international pharmacopoeia standards, such as the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), is imperative for manufacturers to ensure global acceptance and maintain product quality.

4India Regulatory Classification

In India, Bleomycin is classified under Schedule H of the Drugs and Cosmetics Act, indicating that it is a prescription-only medication. The National Pharmaceutical Pricing Authority (NPPA) regulates the pricing of essential medicines; however, as of March 2026, Bleomycin is not listed under the Drug Price Control Order (DPCO), allowing manufacturers to set prices based on market dynamics. For exports, the Directorate General of Foreign Trade (DGFT) mandates a No Objection Certificate (NOC) to ensure compliance with national regulations and to monitor the export of critical pharmaceuticals.

5Patent & Exclusivity Status

The primary patents for Bleomycin have expired, leading to the availability of generic versions in various markets. This expiration has intensified competition among manufacturers, including the 206 active Indian exporters, and has contributed to the widespread accessibility of Bleomycin for cancer treatment globally.

6Recent Industry Developments

In January 2023, the European Medicines Agency (EMA) conducted a Periodic Safety Update Report Single Assessment (PSUSA) for Bleomycin, resulting in a variation to the product information to enhance safety monitoring. (ema.europa.eu) In March 2025, the EMA issued a reminder regarding the contraindication of using Adcetris (brentuximab vedotin) in combination with Bleomycin due to increased pulmonary toxicity risks. (ema.europa.eu) These developments underscore the importance of continuous pharmacovigilance and adherence to updated regulatory guidelines to ensure patient safety and compliance in the pharmaceutical industry.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Bleomycin

Retail & reference prices across 9 markets vs. India FOB export price of $8.22/unit

Global Price Benchmark for Bleomycin across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$1,200	USD	According to the FDA's Orange Book, Bleomycin is an approved injectable antibiotic used in chemotherapy.
United Kingdom	$1,170	GBP	The NHS Drug Tariff lists Bleomycin as an essential medication for cancer treatment.
Germany	$1,100	EUR	The European Medicines Agency (EMA) includes Bleomycin in its list of approved oncology drugs.
Australia	$1,050	AUD

Supply Chain Risk Assessment — Bleomycin

API sourcing, concentration risk, storage requirements, and current alerts

MEDIUM RISK

1API Sourcing & Raw Material Dependency

Bleomycin, an antineoplastic agent, is primarily produced in India. However, the Indian pharmaceutical industry heavily relies on China for Key Starting Materials (KSMs) and intermediates essential for Active Pharmaceutical Ingredient (API) synthesis. According to the U.S. Pharmacopeia's Medicine Supply Map, 41% of KSMs used in U.S.-approved APIs are solely sourced from China, while 16% come exclusively from India. This dependency exposes the supply chain to potential disruptions stemming from geopolitical tensions, trade restrictions, or environmental regulations affecting Chinese manufacturing facilities.

In recent years, China's stringent environmental policies have led to the shutdown of numerous API manufacturers, causing supply shortages and price volatility. For instance, between 2017 and 2018, approximately 145 API manufacturers in China ceased operations due to non-compliance with environmental standards, significantly impacting global API supply chains. Such events underscore the vulnerability of India's pharmaceutical sector, including Bleomycin production, to external supply chain disruptions.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data indicates that the top five Indian exporters of Bleomycin account for 47.9% of total exports, with VENUS REMEDIES LIMITED alone contributing 21.7%. This concentration suggests a moderate risk of supply disruption if any of these key suppliers face operational challenges.

Access Complete Bleomycin Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 1,101 transactions across 119 markets.

Request Demo View Pricing

Frequently Asked Questions — Bleomycin Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top bleomycin exporters from India?

The leading bleomycin exporters from India are VENUS REMEDIES LIMITED, NAPROD LIFE SCIENCES PRIVATE LIMITED, INFUGEN PHARMA PRIVATE LIMITED, and 9 others. VENUS REMEDIES LIMITED leads with 21.7% market share ($1.2M). The top 5 suppliers together control 47.9% of total export value.

What is the total export value of bleomycin from India?

The total export value of bleomycin from India is $5.6M, recorded across 1,101 shipments from 206 active exporters to 119 countries. The average shipment value is $5.1K.

Which countries import bleomycin from India?

India exports bleomycin to 119 countries. The top importing countries are SOUTH AFRICA (9.9%), MOZAMBIQUE (9.9%), UZBEKISTAN (6.3%), MEXICO (6.2%), COLOMBIA (6.2%), which together account for 38.6% of total export value.

What is the HS code for bleomycin exports from India?

The primary HS code for bleomycin exports from India is 30049049. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Bleomycin

Bleomycin

Top Bleomycin Exporters from India

Top Countries Importing Bleomycin from India

Who Supplies Bleomycin to India?

Quick Facts

Related Advanced Oncology

Related Analysis

Need Details?

Regulatory Landscape — Bleomycin

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Bleomycin

Supply Chain Risk Assessment — Bleomycin

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Bleomycin Trade Intelligence

Frequently Asked Questions — Bleomycin Exports from India

Who are the top bleomycin exporters from India?

What is the total export value of bleomycin from India?

Which countries import bleomycin from India?

What is the HS code for bleomycin exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of bleomycin exports from India?

Which ports handle bleomycin exports from India?

Why is India a leading exporter of bleomycin?

What certifications do Indian bleomycin exporters need?

How many buyers import bleomycin from India?

What is the market share of the top bleomycin exporter from India?

Analysis Methodology